InvestmentJul 16, 2026, 08:46 AM
Cardiff Oncology Raises $10.05M in Registered Direct Offering
AI Summary
Cardiff Oncology, Inc. completed a registered direct offering, raising approximately $10.05 million in gross proceeds. The company sold 8,571,429 shares of common stock and accompanying warrants to institutional investors at $1.05 per unit, and 721,649 shares and warrants to certain officers and directors at $1.455 per unit. The net proceeds are intended for working capital and general corporate purposes. H.C. Wainwright & Co. acted as the exclusive placement agent, receiving a 7.0% cash fee and warrants.
Key Highlights
- Raised approximately $10.05 million in gross proceeds from the offering.
- Sold 8,571,429 shares and accompanying warrants to institutional investors at $1.05 per unit.
- Sold 721,649 shares and accompanying warrants to officers and directors at $1.455 per unit.
- Common Warrants exercisable at $1.31 per share ($1.33 for Insiders).
- Placement agent, H.C. Wainwright & Co., received a 7.0% cash fee.
- Placement agent also received warrants to purchase up to 465,157 shares at $1.3125.
Price Impact
More from CRDF